Overview of BionIT

BionIT Labs provides the Adam’s Hand, a next-generation prosthetic hand designed for individuals with traumatic or congenital upper limb differences. Unlike traditional multi-articulating devices that require complex control strategies, the Adam’s Hand features a fully adaptive grip that automatically conforms to the shape and size of any object.

This innovation is made possible through the seamless integration of Mechanical Intelligence and AI-driven pattern recognition, eliminating the need for manual grip selection. The result is an intuitive, natural experience that reduces muscle fatigue and cognitive load by up to four times compared to conventional solutions—while delivering superior strength, durability, and reliability in daily use.

The Adam’s Hand is not only easy to learn and use, but also field-serviceable, waterproof, and designed to support the end user in confidently performing 90% of activities of daily living.

At BionIT Labs, we believe that disabilities are not limitations of the individual—but reflections of the world’s failure to design inclusive, human-centered solutions. We see our role as reimagining these interfaces through technology, creating products that restore function, confidence, and independence.

In an industry where true innovation has been slow, we are proud to deliver products that meaningfully improve ease of use, durability, and end-user experience—addressing challenges that have gone unaddressed for decades.

As a certified Benefit Corporation, we are committed to measurable impact—developing technologies that not only improve daily life, but also promote equity and access across global communities. By removing barriers and expanding possibilities, BionIT Labs is reshaping what’s possible for people with upper limb differences.

BionIT Labs serves individuals with upper limb differences—whether from traumatic injury, congenital conditions, or other causes—who seek intuitive, high-performance assistive technology to enhance their independence and quality of life.

While our primary focus today is on multi-articulating upper limb prosthetics, our long-term vision includes expanding access to other underserved populations in need of user-first assistive technologies. As we grow, we aim to support a broader spectrum of individuals navigating physical challenges—always with innovation, inclusion, and empowerment at the core.

We welcome collaboration with values-aligned partners who share our commitment to accessibility, innovation, and equity in assistive technology.

In the near term, we are actively seeking:

Investors to support the next phase of our global expansion, product roadmap, and commercialization activities

Payers and advocacy organizations interested in expanding access to intuitive, user-centered prosthetic solutions

Strategic partners in assistive or humanoid robotics who are exploring long-term collaboration, investment, or potential acquisition. We believe our innovations in Mechanical Intelligence, adaptive control systems, and inclusive design offer strong synergies with forward-looking technology portfolios.

After six years of deep R&D and design rooted in real user needs, BionIT Labs has redefined what’s possible in upper limb prosthetics. We’ve brought true innovation to a space that has seen little change in decades—launching the world’s first fully adaptive bionic hand and surpassing $1M in revenue in Q1 2025.

With users in over 15 countries and commercial operations now active in the U.S., we’re entering a new phase: expanding our product line, launching new services, and scaling our reach globally.

We’re seeking mission-aligned investors and strategic partners who recognize that the future of assistive technology demands more than incremental change. This is a call to help shape that future—through investment, collaboration, or co-creation of the next generation of inclusive, human-centered solutions.